Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world… Read more
HEOR Feature
Featured
ICER Reveals Prescription Drug Cost Sharing Policies, Concludes Many Will Dislike Findings
A recent ICER whitepaper discusses a range of policies designed to limit drug prices. It focuses on three main topics related to prescription drug… Read more
GOP Avoids Drug Cost Questions During Becerra HHS Hearings
Xavier Becerra is Biden’s pick for HHS (Health and Human Services). Earlier this week, he took questions from Republican lawmakers, covering a wide… Read more
Aetion’s Take on RWE Expansion in Europe
Aetion’s Ashley Jaska, Vice President of Science, and Nicholas Deltour, Vice President of Real-World Solutions, offered their insight into how RWE… Read more
The Latest Blogs from tHEORetically Speaking
- Revealing the Unknown: How the COVID Active Research Experience (CARE) Registry is Enhancing Community Health
- COVID-19 and Racial/Ethnic Disparities in Health
- The 5 Numbers That Will Define Healthcare Value in 2021
- Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement
- How Health Economics and Outcomes Researchers Can Help Defeat COVID-19
Other Biopharma News
The Latest Job Listings from the HealthEconomics.com Jobs Portal
- Job Description - Associate Director / Director - Reimbursement Policy Insights (Remote)
- Principal Scientist, Real World Evidence (RWE) Analytics
- Manager, Reimbursement Policy & Insights (Remote)
- Market Access Analyst / Manager, Agency of Record (Remote)
- Research Scientist (Implementation Science) – Patient-Centered Research
